Journal of Leukocyte Biology · 1999 · 42 citations · 13 references
Life SciencesImmunologySurgeryStem Cell TransplantationTransplant ImmunologyTransplant SurgeryAcute RejectionAllograft RejectionGraft RejectionGraft SurvivalHeart TransplantationTransplant RejectionCellular Rejection MonitoringDonor-recipient ChimerismHematopoietic ChimerismImmunologic Response To AllograftTransplant Tolerance Mechanisms
To further enhance chimerism, 229 primary allograft recipients have received perioperative intravenous infusion of a single dose of 3 to 6 X 10(8) unmodified donor bone marrow (BM) cells/kg body weight. In addition, 42 patients have been accrued in a concurrent protocol involving multiple (up to three) sequential perioperative infusions of 2 x 10(8) BM cells/kg/day from day 0-2 posttransplantation (PTx). Organ recipients (n = 133) for whom BM was not available were monitored as controls. The infusion of BM was safe and except for 50 (18%), all study patients have optimal graft function. Of the control patients, allografts in 30 (23%) have been lost during the course of follow-up. The cumulative risk of acute cellular rejection (ACR) was statistically lower in the study patients compared with that of controls. It is interesting that, 62% of BM-augmented heart recipients were free of ACR (Grade > or = 3A) in the first 6 months PTx compared to controls. The incidence of obliterative bronchiolitis was also statistically lower in study lung recipients (3.8%) compared with the contemporaneously acquired controls (31%). The levels of donor cell chimerism were at least a log higher in the peripheral blood of majority of the study patients compared with that of controls. The incidence of donor-specific hyporeactivity, as determined by one-way mixed leukocyte reaction, was also higher in those BM-augmented liver, kidney, and lung recipients that could be evaluated compared to controls.
13
‘Actively Acquired Tolerance’ of Foreign Cells
R. E. Billingham, L Brent, P. B. Medawar · Nature · 1953 · 3.1K citations
A BIOLOGICAL ROLE FOR THE MAJOR HISTOCOMPATIBILITY ANTIGENS
Peter C. Doherty, Rolf M. Zinkernagel · The Lancet · 1975 · 494 citations
Murine liver allograft transplantation: Tolerance and donor cell chimerism
Shigwang Qian, Anthony J. Demetris, Noriko Murase et al. · Hepatology · 1994 · 458 citations · Full text
WEANING OF IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS12
George Mazariegos, Jorgé Reyes, Ignazio R. Marino et al. · Transplantation · 1997 · 420 citations · Full text
A human XY female with a frame shift mutation in the candidate testis-determining gene SRY
Ralf J. Jäger, Maria Anvret, Kerstin Hall et al. · Nature · 1990 · 412 citations